Level D· Scientific groundwork from lab and animal studiesAnimal StudyEurope PMCOpen access

3D bioprinting of plant and animal cell-based hybrid food

Maharjan S., Yamashita C., Lee CP., Villalobos Zepeda A., Michel Farias AK., Duarte Rivera A.

Animal Study, published in Nat Commun (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Nat Commun (2025)
Reported sample size
—
Source database
Europe PMC
PMID
40721583
PMCID
PMC12304182
DOI
10.1038/s41467-025-61996-4
Citations
4

Abstract (original English)

Cellular agriculture is an emerging field that leverages stem cell biology, biotechnology, and tissue engineering to produce meat and other agricultural products through cell culture techniques. One of the most promising methods within this domain is three-dimensional (3D) bioprinting, which allows for precise layering of cells to form sophisticated structures. In this study, we introduce fully automated chaotic bioprinting with a custom-built extrusion setup taking advantage of an integrated Kenics static mixer printhead to create plant and animal cell-based hybrid noodles. These bioprinted hybrid noodles are made of approximately 30-40% unicellular plant cells (Chlamydomonas or Chlorella microalgae) and 60-70% muscle cells (C2C12 or chicken myoblasts). We further 3D-bioprinted aesthetically appealing hybrid food products of various shapes and sizes, where their textures, nutritional contents, and cooking behaviors are evaluated. This proof-of-concept study demonstrates that 3D bioprinting can reliably produce a distinct category of plant- and animal cell-based hybrid foods and highlights opportunities to create complex culinary designs and explore diverse nutritional profiles with precision and efficiency.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Cell LineMyoblastsAnimalsChickensMiceTissue EngineeringPlant CellsBioprintingPrinting, Three-Dimensional

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.